Latest News

Aroa Biosurgery expands options for soft tissue repair with launch of Myriad™20 Feb 2020

Auckland, NZ. Aroa Biosurgery, the Auckland-based privately held soft-tissue repair company, has launched Myriad™, a new product for soft tissue repair and reconstruction, in the United States market.

Aroa Chief Executive, Brian Ward says the product name, Myriad™, reflects the multitude of potential uses for this product in soft tissue repair and reconstruction.

Continue Reading

Aroa Biosurgery launches large format Endoform® to treat larger, more complex wounds7 Feb 2020

Auckland, NZ. Aroa Biosurgery, the Auckland-based privately held soft-tissue repair company, has now launched a large format version of its Endoform® Natural product.

The largest of Aroa’s wound care products, the 8.5 by 6-inch device has been launched in the United States and Canadian markets, following its recent approval for reimbursement within the U.S. healthcare system.

Continue Reading

Aroa Biosurgery appoints experienced Australian-based director13 Dec 2019

Auckland, NZ. Aroa Biosurgery Limited (Aroa), a New Zealand-headquartered, privately held soft-tissue repair company has appointed highly experienced Australia-based, Non-executive Director, John Diddams to its Board.

Aroa Chair, Jim Mclean says Mr Diddams’ appointment is timely as the company considers its options for raising further capital to fund its next growth phase, which could include seeking new investors in Australia and elsewhere.

Continue Reading
1234567Next ›